Mesenteric Visceral Lipectomy (MVL) Improves Glucose Tolerance in Patients with Type 2 Diabetes (T2D)

被引：0
|
作者：
Baskoy, Gozde
Peterson, Richard M.
Kempenich, Jason W.
Triplitt, Curtis L.
Clarke, Geoffrey D.
Cersosimo, Eugenio
Andrew, Mark S.
Merovci, Aurora
Lavrynenko, Olga
Hansis-Diarte, Andrea A.
Solis-Herrera, Carolina
Chavez, Alberto
Salehi, Marzieh
Defronzo, Ralph A.
机构：
来源：
DIABETES | 2024年 / 73卷
关键词：
D O I：
10.2337/db24-1667-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1667-P
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Mesenteric Visceral Lipectomy Improves Glucose Tolerance in Patients With Type 2 Diabetes: A Pilot Study
    Baskoy, Gozde
    Peterson, Richard M.
    Kempenich, Jason
    Triplitt, Curtis
    Brown, Marissa
    Clarke, Geoffrey D.
    Cersosimo, Eugenio
    Andrew, Mark S.
    Lavrynenko, Olga
    Chavez-Velazquez, Alberto O.
    Hansis-Diarte, Andrea
    Salehi, Marzieh
    Defronzo, Ralph A.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2025,
  • [2] Dietary 1-Kestose Improves Glucose Metabolism in Type 2 Diabetes (T2D) Rat
    Watanabe, Ayako
    ANNALS OF NUTRITION AND METABOLISM, 2019, 75 : 281 - 281
  • [3] Aleglitazar (ALE) Improves Insulin Sensitivity, Glucose Control, and Lipids in People with Type 2 Diabetes (T2D)
    Stirban, Alin O.
    Andjelkovic, Mirjana
    Heise, Tim
    Nosek, Leszek
    Fischer, Annelie
    Gastaldelli, Amalia
    Herz, Matthias
    DIABETES, 2014, 63 : A291 - A291
  • [4] Rosiglitazone once or twice daily improves glycemic control in patients with type 2 diabetes (T2D)
    Grunberger, G
    Weston, WM
    Patwardhan, R
    Rappaport, EB
    DIABETES, 1999, 48 : A102 - A102
  • [5] Risk of Progression to Type 2 Diabetes (T2D) and Regression to Normal Glucose Regulation (NGR) in People with Impaired Glucose Tolerance (IGT)
    Herman, William H.
    Barrett-Connor, Elizabeth L.
    Dabelea, Dana M.
    Edelstein, Sharon L.
    Horton, Edward S.
    Kahn, Steven E.
    Knowler, William C.
    Lorenzo, Carlos
    Mather, Kieren J.
    Perreault, Leigh
    Pan, Qing
    Pi-Sunyer, Xavier
    Venditti, Elizabeth M.
    Ye, Wen
    Zhang, Ping
    DIABETES, 2016, 65 : A370 - A371
  • [6] The Dipeptidyl Peptidase (DPP)-4 Inhibitor Linagliptin Improves β-Cell Function and Postprandial Glucose in Type 2 Diabetes (T2D)
    Patel, Sanjay
    Heise, Tim
    Larbig, Martin
    Weber, Sonja
    Seck, Thomas
    Hehnke, Uwe
    Woerle, Hans J.
    Dugi, Klaus
    DIABETES, 2013, 62 : A296 - A296
  • [7] The Impact of Glucose Variability on Achievement of Glycemic Control and Risk of Hypoglycemia in Patients with Type 2 Diabetes (T2D)
    Umpierrez, Guillermo E.
    Digenio, Andres
    Zhou, Rong
    Inzucchi, Silvio
    DIABETES, 2011, 60 : A310 - A311
  • [8] Liraglutide plus Metformin Delays Worsening of Glycemia in Adults with Impaired Glucose Tolerance (IGT) or Type 2 Diabetes (T2D)
    Sam, Susan
    Edelstein, Sharon
    Utzschneider, Kristina
    Hannon, Tamara S.
    Barengolts, Elena
    Xiang, Anny
    Ehrmann, David A.
    Mather, Kieren J.
    Kahn, Steven E.
    DIABETES, 2020, 69
  • [9] Mechanisms of the Antihyperglycemic Effect of Sitagliptin in Patients with Type 2 Diabetes (T2D)
    Muscelli, Elza
    Casolaro, Arturo
    Gastaldelli, Amalia
    Mari, Andrea
    Seghieri, Giuseppe
    Chen, Yu
    Alba, Maria
    Holst, Jens
    Ferrannini, Ele
    DIABETES, 2011, 60 : A267 - A267
  • [10] Visceral Adiposity Index (VAI) in Youth: A Biomarker of Metabolic Syndrome and Type 2 diabetes (T2D)
    Michaliszyn, Sara F.
    Kerns, Lucy
    Tfayli, Hala
    Bacha, Fida
    Kim, Joon Young
    Arslanian, Silva A.
    DIABETES, 2017, 66 : A369 - A370
12345